Cui Yinji, Song Meiying, Kim Su Young
Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Pathol Int. 2019 Feb;69(2):68-75. doi: 10.1111/pin.12756. Epub 2019 Jan 29.
We conducted this study to identify clinico-pathologic and prognostic factors that are associated with fatty acid binding protein-4 (FABP4) and to discuss its therapeutic potentials in patients with breast cancer (BC). In a total of 75 patients with an established diagnosis of invasive ductal carcinoma of the breast, we performed a retrospective analysis of the medical records and analyzed their immunohistochemical findings. Following evaluation of baseline and clinico-pathological characteristics such as the age, immunohistochemical expressions of FABP4, TNM stage, tumor grade, lymphatic and perineural invasion, estrogen receptor (ER) and progesterone receptor (PR), disease-free survival (DFS), overall survival (OS), recurrence and death, we analyzed correlations of the expression of FABP4 with clinico-pathologic and prognostic factors. Our results showed that tumor grade and recurrence had a significant correlation with the expression of FABP4 (P = 0.002 and 0.049, respectively). Moreover, we also found that the DFS had a significant correlation with the expression of FABP4 (P = 0.049). It can therefore be concluded that the expression of FABP4 might have a prognostic value in patients with BC. But further studies are warranted to establish its potentials as a prognostic indicator.
我们开展这项研究以确定与脂肪酸结合蛋白4(FABP4)相关的临床病理和预后因素,并探讨其在乳腺癌(BC)患者中的治疗潜力。在总共75例已确诊为乳腺浸润性导管癌的患者中,我们对病历进行了回顾性分析,并分析了他们的免疫组化结果。在评估了年龄、FABP4的免疫组化表达、TNM分期、肿瘤分级、淋巴管和神经周围浸润、雌激素受体(ER)和孕激素受体(PR)、无病生存期(DFS)、总生存期(OS)、复发和死亡等基线和临床病理特征后,我们分析了FABP4表达与临床病理和预后因素的相关性。我们的结果表明,肿瘤分级和复发与FABP4的表达有显著相关性(分别为P = 0.002和0.049)。此外,我们还发现DFS与FABP4的表达有显著相关性(P = 0.049)。因此可以得出结论,FABP4的表达可能对BC患者具有预后价值。但需要进一步研究以确定其作为预后指标的潜力。